We are live on ! Find out more
EOJOAM

E. Ohman J:or Asset Management Portfolio holdings

AUM $4.3B
1-Year Est. Return 29.55%
This Fund
S&P 500
This Quarter Est. Return
-3.19%
1 Year Est. Return
+29.55%
3 Year Est. Return
+110.24%
5 Year Est. Return
+144.75%
10 Year Est. Return
+695.34%
AUM
$2.65B
AUM Growth
-$120M
Cap. Flow
-$673K
Cap. Flow %
-0.03%
Top 10 Hldgs %
39.69%
Holding
444
New
21
Increased
84
Reduced
61
Closed
28

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$31.1M
2
LW icon
Lamb Weston
LW
+$29.3M
3
META icon
Meta Platforms (Facebook)
META
+$21M
4
UNH icon
UnitedHealth
UNH
+$10.6M
5
HDB icon
HDFC Bank
HDB
+$8.44M

Top Sells

Rank Stock Value
1
CL icon
Colgate-Palmolive
CL
+$37.8M
2
HOLX
Hologic
HOLX
+$27.6M
3
EW icon
Edwards Lifesciences
EW
+$26.2M
4
ABT icon
Abbott
ABT
+$8.59M
5
AMD icon
Advanced Micro Devices
AMD
+$8.42M

Sector Composition

Rank Sector Weight
1 Technology 31.23%
2 Healthcare 15.05%
3 Financials 14.66%
4 Consumer Discretionary 12.23%
5 Communication Services 11.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VMW
151
DELISTED
VMware, Inc
VMW
$1.76M 0.07%
10,581
+600
+6% +$96.1K
RDUS
152
DELISTED
Radius Recycling
RDUS
$1.76M 0.07%
63,200
GIS icon
153
General Mills
GIS
$19.9B
$1.76M 0.07%
27,500
IBP icon
154
Installed Building Products
IBP
$6.27B
$1.76M 0.07%
14,054
-5,200
-27% -$734K
TRV icon
155
Travelers Companies
TRV
$78.3B
$1.75M 0.07%
10,692
PAYX icon
156
Paychex
PAYX
$43.1B
$1.74M 0.07%
15,100
+900
+6% +$108K
RDNT icon
157
RadNet
RDNT
$6.08B
$1.74M 0.07%
+61,700
New +$1.92M
NIO icon
158
NIO
NIO
$12.1B
$1.72M 0.06%
190,300
-12,000
-6% -$134K
CNC icon
159
Centene
CNC
$32.9B
$1.71M 0.06%
24,894
EXC icon
160
Exelon
EXC
$45.8B
$1.7M 0.06%
44,924
STEM icon
161
Stem
STEM
$50.9M
$1.7M 0.06%
20,000
APO icon
162
Apollo Global Management
APO
$76B
$1.69M 0.06%
18,800
SPG icon
163
Simon Property Group
SPG
$71.5B
$1.69M 0.06%
15,600
DXCM icon
164
DexCom
DXCM
$33.1B
$1.68M 0.06%
18,000
DD icon
165
DuPont de Nemours
DD
$19.1B
$1.67M 0.06%
17,841
BIIB icon
166
Biogen
BIIB
$30.6B
$1.67M 0.06%
6,499
-400
-6% -$107K
IDXX icon
167
Idexx Laboratories
IDXX
$46.9B
$1.66M 0.06%
3,800
DOW icon
168
Dow Inc
DOW
$22.1B
$1.64M 0.06%
31,900
-1,700
-5% -$91.3K
IQV icon
169
IQVIA
IQV
$39.8B
$1.63M 0.06%
8,301
PRU icon
170
Prudential Financial
PRU
$42.1B
$1.62M 0.06%
17,023
HWC icon
171
Hancock Whitney
HWC
$6.23B
$1.61M 0.06%
43,600
CTVA icon
172
Corteva
CTVA
$51B
$1.61M 0.06%
31,500
VRSK icon
173
Verisk Analytics
VRSK
$23.6B
$1.6M 0.06%
6,773
FNA
174
DELISTED
Paragon 28, Inc.
FNA
$1.58M 0.06%
125,500
+10,100
+9% +$152K
AME icon
175
Ametek
AME
$58B
$1.57M 0.06%
10,600

Similar funds

E. Ohman J:or Asset Management's Q3 2023 Portfolio in Review

As of Q3 2023, E. Ohman J:or Asset Management held 444 positions worth $2.65B, down 4.3% from $2.77B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

E. Ohman J:or Asset Management's Q3 2023 filing shows 21 new, 84 increased, 61 reduced and 28 closed positions. Its largest new stake was Meta Platforms (Facebook): 69,800 shares worth $21M. The largest sale was Colgate-Palmolive, an estimated $37.8M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.

  • E. Ohman J:or Asset Management's largest Q3 2023 buy was Meta Platforms (Facebook): 69,800 shares worth $21M.
  • E. Ohman J:or Asset Management added most to Boston Scientific in Q3 2023, an estimated $31.1M increase.
  • E. Ohman J:or Asset Management's biggest Q3 2023 reduction was Colgate-Palmolive, cutting an estimated $37.8M.
  • E. Ohman J:or Asset Management fully exited Abbott in Q3 2023, selling an estimated $8.59M.
  • E. Ohman J:or Asset Management's ten largest holdings make up 40% of its $2.65B portfolio in Q3 2023.
  • E. Ohman J:or Asset Management opened 21 new positions and closed 28 in Q3 2023.
  • E. Ohman J:or Asset Management's portfolio value fell 4.3% quarter-over-quarter to $2.65B.

Based on E. Ohman J:or Asset Management's 13F filing for Q3 2023, filed 6 Feb 2024.